Why India's First Dengue Vaccine Marks a Public Health Milestone

As climate change, rapid urbanisation and population growth fuel the spread of dengue, CDSCO's approval of Takeda's Qdenga marks a significant step in India's disease prevention strategy. With reported dengue cases rising 11-fold over the past two decades, doctors say the country's first dengue vaccine could reduce severe disease, hospitalisations and deaths, while calling for its eventual inclusion in the National Immunisation Programme.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SF6ybRY
via gqrds